Targeted Cytomegalovirus Testing Linked to Newborn Hearing Screening Was Feasible but Had Low Diagnostic Yield
Acta Paediatrica · 2026
DOI: 10.1111/apa.70354 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Paediatrica, 2026. Verfasst von Emilie Luppescu Pedersen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics and Adolescent Medicine, Slagelse Hospital, Slagelse, Denmark. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Neonatal Screening, Hearing Loss. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Næstved, Slagelse og Rigsted Sygehus' forskningsfond.
Abstract (Originalsprache)
Aims
Congenital cytomegalovirus is the leading cause of non‐genetic hearing loss in children. This study aimed to evaluate if hearing‐targeted screening for congenital cytomegalovirus was implementable and whether it improved timely treatment of affected newborns.
Methods
This retrospective cohort study included newborns who did not pass hearing screening in Region Zealand, Denmark. The study period was 1 June 2018 to 31 May 2024, covering 4 years before and 2 years after the implementation of hearing‐targeted cytomegalovirus screening. We compared the proportion of infants tested, age at testing, and the use of saliva and urine samples.
Results
During the 6 years, 615 infants did not pass the hearing screening. Before the implementation of hearing targeted screening, 21 of 349 referred infants (6%) were tested for cytomegalovirus. By the second year of implementation, testing increased to 113 (90%). Saliva and urine samples were collected from the same number of infants. Nine of 11 positive saliva samples were not confirmed infections. No children with cytomegalovirus‐related hearing loss were diagnosed in time to initiate treatment.
Conclusion
In our setting, hearing targeted cytomegalovirus screening was gradually implemented, but had low diagnostic yield. Urine samples seemed preferable to saliva for targeted screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Paediatrics and Adolescent Medicine, Slagelse Hospital, Slagelse, Denmark.
- Department of Paediatrics and Adolescent Medicine, Holbaek Hospital, Holbaek, Denmark.
- Department of Audiology, Zealand University Hospital, Køge, Denmark.
- Department of Paediatrics, Zealand University Hospital, Roskilde, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Department of Clinical Microbiology, Region Zealand, Slaglelse, Denmark.
ORCID-Profile: Emilie Luppescu Pedersen, Stine Lund
Förderung
- Næstved, Slagelse og Rigsted Sygehus' forskningsfond
Zitieren
APA
Pedersen, E. L., Hvilsted, K. F., Moritz, J., Jensen, L. H., Stanchev, H., Madsen, T. V., Johansen, R. L., Nielsen, X. C., Zaharova, T., Andersen, D. V., Nygaard, U., Lund, S., & Rytter, M. J. H. (2026). Targeted Cytomegalovirus Testing Linked to Newborn Hearing Screening Was Feasible but Had Low Diagnostic Yield. Acta Paediatrica. https://doi.org/10.1111/apa.70354
Vancouver
Pedersen EL, Hvilsted KF, Moritz J, Jensen LH, Stanchev H, Madsen TV, et al. Targeted Cytomegalovirus Testing Linked to Newborn Hearing Screening Was Feasible but Had Low Diagnostic Yield. Acta Paediatrica. 2026. doi:10.1111/apa.70354
BibTeX
@article{Pedersen2026,
author = {Pedersen, Emilie Luppescu and Hvilsted, Kirsten Fenger and Moritz, Janko and Jensen, Lise Heilmann and Stanchev, Hristo and Madsen, Tina Vasehus and Johansen, Rikke Lykke and Nielsen, Xiaohui Chen and Zaharova, Tatjana and Andersen, Dorthe Vestergaard and Nygaard, Ulrikka and Lund, Stine and Rytter, Maren Johanne Heilskov},
title = {Targeted Cytomegalovirus Testing Linked to Newborn Hearing Screening Was Feasible but Had Low Diagnostic Yield},
journal = {Acta Paediatrica},
year = {2026},
doi = {10.1111/apa.70354}
}
EUVIMED